4.7 Article

Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma

Related references

Note: Only part of the references are listed.
Article Nanoscience & Nanotechnology

Glucose and Triphenylphosphonium Co-Modified Redox-Sensitive Liposomes to Synergistically Treat Glioma with Doxorubicin and Lonidamine

Yao Peng et al.

Summary: The study successfully delivered doxorubicin and lonidamine to glioma cells using multitargeted redox-sensitive liposomes, showing a synergistic effect with significant anti-tumor efficacy by inhibiting cell proliferation and inducing apoptosis.

ACS APPLIED MATERIALS & INTERFACES (2021)

Review Pharmacology & Pharmacy

Clinical applications of nanomedicine in cancer therapy

Mohammad Norouzi et al.

DRUG DISCOVERY TODAY (2020)

Review Chemistry, Multidisciplinary

Dual and multi-targeted nanoparticles for site-specific brain drug delivery

Yan Luo et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Article Chemistry, Multidisciplinary

Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma

Haiyan Guo et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Review Biochemistry & Molecular Biology

Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy

Lanfeng Dong et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Chemistry, Multidisciplinary

Guiding Drugs to Target-Harboring Organelles: Stretching Drug-Delivery to a Higher Level of Resolution

Sivan Louzoun-Zada et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)

Article Chemistry, Medicinal

Dual-targeting liposomes with active recognition of GLUT5 and αvβ3 for triple-negative breast cancer

Yanchi Pu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Cell Biology

Mitochondrial Involvement in Migration, Invasion and Metastasis

Tatiana Denisenko et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Review Chemistry, Multidisciplinary

Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment

Lakshmi Pallavi Ganipineni et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Article Biochemistry & Molecular Biology

Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation

Yao Peng et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2018)

Article Oncology

Combine and conquer: challenges for targeted therapy combinations in early phase trials

Juanita S. Lopez et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Chemistry, Multidisciplinary

Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery

Zakia Belhadj et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Article Nanoscience & Nanotechnology

Mitochondrial-Targeting Lonidamine-Doxorubicin Nanoparticles for Synergistic Chemotherapy to Conquer Drug Resistance

Yanqiu Liu et al.

ACS APPLIED MATERIALS & INTERFACES (2017)

Article Oncology

ATP-P2Y2--catenin axis promotes cell invasion in breast cancer cells

Jiang-Lan Zhang et al.

CANCER SCIENCE (2017)

Review Pharmacology & Pharmacy

Combination antitumor therapy with targeted dual-nanomedicines

Wenbing Dai et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Review Pharmacology & Pharmacy

Doxorubicin: nanotechnological overviews from bench to bedside

Maximiliano Cagel et al.

DRUG DISCOVERY TODAY (2017)

Editorial Material Pharmacology & Pharmacy

Killing two birds or more with one stone

Chan Yeong Heo et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Review Pharmacology & Pharmacy

Progress and perspectives on targeting nanoparticles for brain drug delivery

Huile Gao

ACTA PHARMACEUTICA SINICA B (2016)

Article Pharmacology & Pharmacy

The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model

Mona Alibolandi et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)

Review Oncology

Epidemiologic and Molecular Prognostic Review of Glioblastoma

Jigisha P. Thakkar et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)

Review Pharmacology & Pharmacy

PEGylated nanomedicines: recent progress and remaining concerns

Driton Vllasaliu et al.

EXPERT OPINION ON DRUG DELIVERY (2014)

Article Biochemistry & Molecular Biology

Charge-Conversional and pH-Sensitive PEGylated Polymeric Micelles as Efficient Nanocarriers for Drug Delivery

Gong-Yan Liu et al.

MACROMOLECULAR BIOSCIENCE (2014)

Article Multidisciplinary Sciences

p-Hydroxybenzoic acid (p-HA) modified polymeric micelles for brain-targeted docetaxel delivery

Zhang ZhiXin et al.

CHINESE SCIENCE BULLETIN (2013)

Article Biotechnology & Applied Microbiology

The Possible Proton Sponge Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH

Rikke V. Benjaminsen et al.

MOLECULAR THERAPY (2013)

Review Chemistry, Multidisciplinary

Doxil® - The first FDA-approved nano-drug: Lessons learned

Yechezkel (Chezy) Barenholz

JOURNAL OF CONTROLLED RELEASE (2012)

Article Pharmacology & Pharmacy

Benzamide analogue-conjugated polyethylenimine for brain-targeting and gene delivery

Jin Li et al.

JOURNAL OF DRUG TARGETING (2011)

Article Chemistry, Multidisciplinary

Targeted charge-reversal nanoparticles for nuclear drug delivery

Peisheng Xu et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)

Article Chemistry, Medicinal

Conformationally-flexible benzamide analogues as dopamine D3 and σ2 receptor ligands

RH Mach et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)